David Colleran Anika Therapeutics, Inc. (ANIK) insider trading activity

David Colleran is EVP, General Counsel, Corp Sec of Anika Therapeutics, Inc.. Currently has a direct ownership of 47,954 shares of ANIK, which is worth approximately $672,315. The most recent transaction as insider was on Mar 17, 2025, when has been sold 1,893 shares (Common Stock) at a price of $15.91 per share, resulting in proceeds of $30,117. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48K

45.34% 3M change

45.34% 12M change

Total Value Held $672,315

David Colleran Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 17 2025	SELL Payment of exercise price or tax liability	$30,117 $15.91 p/Share	1,893 Reduced 3.8%	47,954 Common Stock
Mar 17 2025	BUY Exercise of conversion of derivative security	-	6,448 Added 11.45%	49,847 Common Stock
Mar 11 2025	SELL Payment of exercise price or tax liability	$37,777 $16.79 p/Share	2,250 Reduced 4.93%	43,399 Common Stock
Mar 11 2025	BUY Exercise of conversion of derivative security	-	7,663 Added 14.37%	45,649 Common Stock
Mar 10 2025	SELL Payment of exercise price or tax liability	$26,658 $16.62 p/Share	1,604 Reduced 4.05%	37,986 Common Stock
Mar 10 2025	BUY Exercise of conversion of derivative security	-	5,465 Added 12.13%	39,590 Common Stock
Mar 11 2024	SELL Payment of exercise price or tax liability	$126,065 $25.54 p/Share	4,936 Reduced 13.01%	32,995 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	-	16,809 Added 32.29%	35,245 Common Stock
Mar 10 2023	SELL Payment of exercise price or tax liability	$58,725 $26.1 p/Share	2,250 Reduced 9.98%	20,288 Common Stock
Mar 10 2023	BUY Exercise of conversion of derivative security	-	7,663 Added 25.37%	22,538 Common Stock
Mar 09 2023	SELL Payment of exercise price or tax liability	$29,089 $26.91 p/Share	1,081 Reduced 6.77%	14,875 Common Stock
Mar 09 2023	BUY Exercise of conversion of derivative security	-	3,683 Added 18.75%	15,956 Common Stock
Mar 04 2023	SELL Payment of exercise price or tax liability	$23,187 $31.59 p/Share	734 Reduced 5.64%	12,273 Common Stock
Mar 04 2023	BUY Exercise of conversion of derivative security	-	2,500 Added 16.12%	13,007 Common Stock
May 11 2022	BUY Open market or private purchase	$32,055 $21.37 p/Share	1,500 Added 13.2%	9,867 Common Stock
Mar 14 2022	BUY Open market or private purchase	$39,975 $26.65 p/Share	1,500 Added 15.2%	8,367 Common Stock
Mar 09 2022	SELL Payment of exercise price or tax liability	$28,344 $26.22 p/Share	1,081 Reduced 13.6%	6,867 Common Stock
Mar 09 2022	BUY Exercise of conversion of derivative security	-	3,682 Added 31.66%	7,948 Common Stock
Mar 04 2022	SELL Payment of exercise price or tax liability	$22,798 $31.06 p/Share	734 Reduced 14.68%	4,266 Common Stock
Mar 04 2022	BUY Exercise of conversion of derivative security	-	2,500 Added 33.33%	5,000 Common Stock
Mar 04 2021	BUY Exercise of conversion of derivative security	-	2,500 Added 50.0%	2,500 Common Stock

David Colleran

EVP, General Counsel, Corp Sec

Bedford, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIK shares.

Notify only if

Value

Insider Trading

Get notified when an Anika Therapeutics, Inc. insider buys or sells ANIK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Anika Therapeutics, Inc.

Track Activities on ANIK

Account